1st Divison :
Oncology
2nd Divison :
Heart, Lung, Blood diseases
3rd Divison :
Diabetes, Digestive & Kidney diseases
4th Divison :
Allergic and Immunological Disorders
5th Divison :
Mental Neurological, Sensory & Motor organ disorders
6th Divison :
Child Health & Human Reproduction & Development
7th Divison :
Bioimaging and Bioengineering Oncology
8th Divison :
Kitano Research Center for Preventive, Epidemiological, Emergency, and Laboratory Medicine
9th Divison :
Pharmaceutics and Physiology
10th Divison :
Nursing Research


Message

Eri Muso M.D., Ph.D

Associate Director
The Tazuke Kofukai Medical Research Institute

At the Tazuke Kofukai Medical Research Institute at Kitano Hospital, with the doctorfs duty of clinical medicine as our cornerstone, we seek to shed light on pathology while delving into unsolved areas and developing new strategies for treatment. The Institute was founded in 1924 with this philosophy in mind, and three years later the Kitano Hospital was established as a clinical hospital to support research. In our daily medical practice, we keep this history in mind?the endeavor of medical treatment is at heart an endeavor of research. Collaboration with the Kyoto University Medical Research Department is fundamental to us, and we use human exchange to the fullest in communicating the fruits of our clinical and basic research not only to Japan, but to the world at large.

The progress of modern medical research, both clinical and basic, is a splendid thing, and research that has a direct application to many forms of treatment has become familiar to us through the speed and breadth of information transmission. At Kitano Hospital, which practices clinical medicine with a research perspective, we fulfill the ideals of gtranslational research,h putting this information to practical use, and take great pride in our high level of medical treatment. We aim to pinpoint the causes of illness and challenge what is possible in the development and verification of new treatments. To keep pace with amazing developments in various fields of medical research, in October 2008, we reorganized our existing five research sections and newly established our medical research divisions 1 through 10 by theme. Along with our Clinical Research Center, this makes a total of 11 divisions, and we reported this to the Ministry of Education, Sports, Culture, Science, and Technology (MEXT). With these divisions, including co-medical departments such as pharmacology and nursing, the entire institution has taken a stance positive to research groups. In addition, our research seminars that were held bimonthly are now held every month, so that we might advance our studies further.

There are harsh aspects to the present state of medical treatment, and in situations of clinical research, too, morality has been rigorously questioned in recent years. In response to this, I will say that our adherence to the Declaration of Helsinki (the October 2008 revision) is a matter of course. Consulting with an ethics committee comprising members from both within and outside of the Institute, and cooperating with the Kyoto University Hospital Translational Research Center, we place the utmost importance on reaching our research goals impartially and responsibly. To support this research system, we consider the maintenance of research infrastructure essential, and since April 2008 the existing laboratory administration committee has held six section meetings on lab maintenance, research planning support, data management, promoting collaboration with graduate schools, and so forth, implementing a responsive system to enrich the research environment. We select administration committee members from all divisions, speeding up the transfer of information.

Financial support is necessary for our research, and we also aim to use the fruits of our research in obtaining public funding from the MEXT and the Ministry of Health, Labour and Welfare, as well as private sector grants. Happily, we also receive significant financial support from patients and from volunteers who donate, and we extend our deepest thanks. We ask that you continue your charity for the future of the young researchers embarking on their careers.

Moving forward, we would like to further promote collaboration within the Institute and with other establishments, and encourage active participation from all directions, so that the fruits of our research keep their clinical roots and truly contribute to the field of health care at large.

About of Medical Research Institute

MEDICAL RESEARCH INSTITUTE President Masao Mitsuyama
Acting President Takashi Uchiyama
Associate Director Eri Muso

1st Division Kitano Research Center for Oncology (KRCO) Kiyoaki Yamauchi, M.D., Ph.D., Director
2nd Division Kitano Research Center for Heart, Lung, Blood diseases (KRCHLB) Motonari Fukui, M.D., Ph.D., Director
3rd Division Kitano Research Center for Diabetes, Digestive & Kidney diseases (KRCDDK) Hiroyuki Koshiyama, M.D., Ph.D., Director
4th Division Kitano Research Center for Allergic and Immunological DisordersiKRCAIDj Masato Yagita, M.D., Ph.D., Director
5th Division Kitano Research Center for Mental Neurological, Sensory & Motor organ disorders (KRCMNSM) Sadayuki Matsumoto, M.D., Ph.D., Director
6th Division Kitano Research Center for Child Health & Human Reproduction & Development (KRCCHRD) Masayasu Koyama, M.D., Ph.D., Director
7th Division Kitano Research Center for Bioimaging and Bioengineering (KRCBB) Ryosuke Okumura, M.D., Ph.D., Director
8th Division Kitano Research Center for Preventive, Epidemiological, Emergency, and Laboratory Medicine (KRCPEEL) Hajime Nakamura, M.D., Ph.D., Director
9th Division Kitano Research Center for Pharmaceutics and Physiology (KRCPP) Takehiko Adachi, M.D., Ph.D., Director
10th Division Kitano Research Center for Nursing Research(KRCNR) Midori Matsuzuki, Director
 
 

 

2-4-20 Ohgimachi,Kita-ku,Osaka,JAPAN,530-8480
FACSIMILE:+81-6-6361-0588

Copyright (c) All Rights Reserved. KITANO HOSPITAL